Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease

被引:51
作者
Acharya, Chathur [1 ,2 ]
Bajaj, Jasmohan S. [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA
[2] Cent Virginia Vet Healthcare Syst, 1201 Broad Rock Blvd, Richmond, VA 23249 USA
关键词
Cirrhosis; Hepatic Encephalopathy; Fecal Microbial Transplant; Diet; CHRONIC HEPATITIS-C; INTESTINAL MICROBIOTA; ALCOHOLIC HEPATITIS; BILE-ACIDS; NONALCOHOLIC STEATOHEPATITIS; PROBIOTIC VSLNUMBER-3; ELDERLY-PATIENTS; DIETARY FIBER; BRAIN AXIS; CIRRHOSIS;
D O I
10.1053/j.gastro.2020.10.056
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is reaching epidemic proportions with the increasing prevalence of obesity, nonalcoholic liver disease, and alcohol overuse worldwide. Most patients are not candidates for liver transplantation even if they have end-stage liver disease. There is growing evidence of a gut microbial basis for many liver diseases, therefore, better diagnostic, prognostic, and therapeutic approaches based on knowledge of gut microbiota are needed. We review the questions that need to be answered to successfully translate our knowledge of the intestinal microbiome and the changes associated with liver disease into practice.
引用
收藏
页码:556 / 572
页数:17
相关论文
共 154 条
  • [1] Acharya C, 2017, ALIMENT PHARM THER, V45, P319, DOI [10.1111/apt.13858, 10.1111/apt.14585]
  • [2] Altered Microbiome in Patients With Cirrhosis and Complications
    Acharya, Chathur
    Bajaj, Jasmohan S.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (02) : 307 - 321
  • [3] Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy
    Agrawal, Amit
    Sharma, Barjesh Chander
    Sharma, Praveen
    Sarin, Shiv Kumar
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) : 1043 - 1050
  • [4] Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
    Ahluwalia, Vishwadeep
    Betrapally, Naga S.
    Hylemon, Phillip B.
    White, Melanie B.
    Gillevet, Patrick M.
    Unser, Ariel B.
    Fagan, Andrew
    Daita, Kalyani
    Heuman, Douglas M.
    Zhou, Huiping
    Sikaroodi, Masoumeh
    Bajaj, Jasmohan S.
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [5] The gut-liver axis in liver disease: Pathophysiological basis for therapy
    Albillos, Agustin
    de Gottardi, Andrea
    Rescigno, Maria
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 558 - 577
  • [6] Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
    Albillos, Agustin
    Lario, Margaret
    Alvarez-Mon, Melchor
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1385 - 1396
  • [7] Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial
    Allegretti, Jessica R.
    Kassam, Zain
    Carrellas, Madeline
    Mullish, Benjamin H.
    Marchesi, Julian R.
    Pechlivanis, Alexandros
    Smith, Mark
    Gerardin, Ylaine
    Timberlake, Sonia
    Pratt, Daniel S.
    Korzenik, Joshua R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (07) : 1071 - 1079
  • [8] Gut microbiome alterations in patients with stage 4 hepatitis C
    Aly, AbdelRahman Mahmoud
    Adel, AbdelReheem
    El-Gendy, Ahmed Osama
    Essam, Tamer M.
    Aziz, Ramy K.
    [J]. GUT PATHOGENS, 2016, 8
  • [9] Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042
  • [10] Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation
    Annavajhala, Medini K.
    Gomez-Simmonds, Angela
    Macesic, Nenad
    Sullivan, Sean B.
    Kress, Anna
    Khan, Sabrina D.
    Giddins, Marla J.
    Stump, Stephania
    Kim, Grace I.
    Narain, Ryan
    Verna, Elizabeth C.
    Uhlemann, Anne-Catrin
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)